4.03MMarket Cap0.29P/E (TTM)
3.3700High2.9709Low8.86KVolume3.3700Open3.1405Pre Close27.83KTurnover0.67%Turnover RatioLossP/E (Static)1.36MShares11.475052wk High0.21P/B3.94MFloat Cap2.720052wk Low--Dividend TTM1.33MShs Float362.5000Historical High--Div YieldTTM12.71%Amplitude2.7200Historical Low3.1390Avg Price1Lot Size
Synaptogenix Stock Forum
Synaptogenix Announces New Collaboration with LSU Health New Orleans for Study of Proprietary Analogs in Spinal Cord Injury
Synaptogenix (NASDAQ: SNPX) has announced a new collaboration with LSU Health New Orleans' Neuroscience Center of Excellence to test its polyunsaturated fatty acid (PUFA) analogs for treating spinal cord injury (SCI). The company also received US Patent No. 12,016,837 for its PUFA analogs in treating neurodegenerative diseases.
The study will com...
Synaptogenix Announces FDA Authorization of Ind Application for Clinical Trial for Bryostatin-1 in Multiple Sclerosis
$Beneficient (BENF.US)$ $Selina Hospitality (SLNA.US)$ $Jaguar Health (JAGX.US)$ $Edible Garden (EDBL.US)$ $Allarity Therapeutics (ALLR.US)$ $Synaptogenix (SNPX.US)$
📊⚡️📊
$Inspire Veterinary Partners (IVP.US)$ $Synaptogenix (SNPX.US)$ $Eco Wave Power (WAVE.US)$ $Biophytis (BPTS.US)$ $CXApp (CXAI.US)$ $Brainstorm Cell Therapeutics (BCLI.US)$
📊⚡️📊
$Singular Genomics (OMIC.US)$
No comment yet